SCHEMBL23788658

SCHEMBL23788658

CC(C)CCCCCC(=O)NCCC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.44
CNR2 P34972 1/20 0.44
KDM4C Q9H3R0 2/20 0.44
KDM4A O75164 1/20 0.44
PHF8 Q9UPP1 1/20 0.44
KDM2A Q9Y2K7 1/20 0.44
LMNA P02545 1/20 0.43
PKM P14618 1/20 0.43
FAAH O00519 4/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24907175 0.90 NAMPT (0.45) CNR1CNR2KDM4CKDM4APHF8
SCHEMBL28340875 0.90 NAMPT (0.45) CNR1CNR2KDM4CKDM4APHF8
SCHEMBL24193602 0.89 CNR1 (0.43) CNR1CNR2LMNAPKMFAAH
SCHEMBL24490138 0.87 LMNA (0.50) CNR1CNR2LMNAPKMFAAH
SCHEMBL20287600 0.86 ALDH1A1 (0.52) CNR1CNR2LMNAPKMALDH1A1
SCHEMBL425951 0.86 ALDH1A1 (0.55) CNR1CNR2KDM4CKDM4APHF8
SCHEMBL24950257 0.85 LMNA (0.51) CNR1CNR2LMNAPKMFAAH
SCHEMBL24701333 0.84 CNR1 (0.43) CNR1CNR2KDM4CKDM4APHF8
SCHEMBL23790088 0.84 FAAH (0.47) FAAHALDH1A1TSHRSIGMAR1DNM1
SCHEMBL24818366 0.84 NAMPT (0.52) CNR1CNR2KDM4CKDM4APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220401564-A1 SELECTIVE HISTONE DEACETYLASE (HDAC) DEGRADERS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-12-22 US disclosed
US-20210276996-A1 DEGRADERS THAT TARGET PROTEINS VIA KEAP1 DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220401564-A1 SELECTIVE HISTONE DEACETYLASE (HDAC) DEGRADERS AND METHODS OF USE THEREOF HDAC3, HDAC1, HDAC2 CNR1 2497/4885CNR2 3097/4885KDM4C 66/4885
US-20210276996-A1 DEGRADERS THAT TARGET PROTEINS VIA KEAP1 KEAP1, CUL3, CUL2 CNR1 4416/4885CNR2 4715/4885KDM4C 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.